Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-01-04

Clinical Trial Update: NanOss Bioactive With Autograft and Bone Marrow Aspirate in the Posterolateral Spine [NA]

View source ↗

Summary

A clinical trial evaluating NanOss Bioactive with autograft and bone marrow aspirate for lumbar spinal stenosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NanOss Bioactive With Autograft and Bone Marrow Aspirate

Snippet

Sponsor: Pioneer Surgical Technology, Inc. | Conditions: Lumbar Spinal Stenosis Secondary to Other Disease | NA | Status: WITHDRAWN